ACAD
31.75
-0.53
-1.64%
AEMD
0.26
-0.02
-6.08%
APRI
1.23
+0.02
+1.23%
ARNA
4.77
+0.15
+3.14%
ATEC
1.31
-0.04
-2.96%
CFN
59.74
-0.07
-0.12%
CNAT
6.1
+0.35
+6.10%
CRXM
0.2
0.00
-0.01%
CYTX
0.5
+0.00
+0.54%
DXCM
62.39
-0.39
-0.62%
GNMK
13.53
+0.25
+1.88%
HALO
14.49
+0.05
+0.35%
ILMN
203.25
+1.57
+0.78%
INNV
0.2
-0.03
-11.16%
INO
8.96
+0.08
+0.88%
ISCO
0.06
0.00
0.00%
ISIS
72.35
-0.55
-0.75%
LGND
58.75
+2.19
+3.87%
LPTN
2.92
0.00
0.00%
MBVX
1.11
-0.06
-5.13%
MEIP
3.68
0.00
0.00%
MNOV
3.45
-0.14
-3.90%
MRTX
21
+1.1
+5.53%
MSTX
0.46
-0.01
-2.13%
NBIX
33.5
-0.05
-0.15%
NUVA
46.96
+0.13
+0.28%
ONCS
0.39
0.00
-0.88%
ONVO
6.63
-0.12
-1.72%
OREX
5.69
+0.13
+2.34%
OTIC
34.48
+2.58
+8.09%
QDEL
24.97
+0.28
+1.13%
RCPT
116.79
+1.05
+0.91%
RGLS
18.89
-0.53
-2.73%
RMD
65.2
-1.97
-2.93%
SCIE
0.01
0.00
0.00%
SPHS
0.47
+0.00
+0.17%
SRNE
10.59
0.00
0.00%
TROV
5.99
+0.09
+1.53%
VICL
1.04
-0.04
-3.70%
VOLC
17.97
-0.01
-0.06%
ZGNX
1.39
+0.06
+4.51%
Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

QIAGEN N.V. Demonstrates Expanded Bioinformatics Workflows At American Society of Human Genetics; Strong Market Adoption As Researchers Analyze Genomic Data On More Than A Quarter-Million Samples In Secure Private Cloud

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO and HILDEN, Germany, October 17, 2014 /PRNewswire/ — Translational research in cancer and other diseases will benefit from new capabilities being presented at the American Society of Human Genetics annual meeting Volume of 250,000-plus DNA samples linked to Ingenuity Knowledge Base greatly exceeds any comparable database – providing superior depth for genomic…

Affymetrix (Santa Clara, California) Exclusively Licenses Technology From For HLA Typing From Genotyping Data

October 20, 2014 – 5:00 am | Edit Post

SANTA CLARA, Calif.–(BUSINESS WIRE)–Affymetrix (NASDAQ:AFFX) announced today that it has exclusively licensed technology from Peptide Groove LLP that enables HLA typing of human samples from genotyping data generated from a variety of assays including the company’s Axiom genotyping assays. The partners at Peptide Groove LLP developed HLA*IMP, the first HLA typing statistical imputation method which…

CytRx Corporation Announces Publication Of Phase 1b/2 Aldoxorubicin Clinical Data In Soft Tissue Sarcoma In Cancer, The Peer-Reviewed

October 20, 2014 – 5:00 am | Edit Post

LOS ANGELES, Oct. 20, 2014 /PRNewswire/ –CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that a paper, titled “A Phase 1b/2 Study of Aldoxorubicin in Patients With Soft Tissue Sarcoma,” has been published online in Cancer, the prestigious…

ResMed Inc. Launches Data Exchange

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –ResMed (NYSE:RMD) today announced the availability of the ResMed Data Exchange program, a comprehensive suite of software and service solutions for home medical equipment (HME) and other health care providers. ResMed Data Exchange offers timely, secure access to…

Genervon Announces ALS And PD Phase 2a Trial Results

October 20, 2014 – 5:00 am | Edit Post

PASADENA, Calif.–(BUSINESS WIRE)–Genervon Biopharmaceuticals LLC (Genervon) today announced that it has completed the analysis of its Phase 2a double blinded, randomized, placebo controlled clinical trials of Amyotrophic Lateral Sclerosis (ALS)(NCT01854294) and Parkinsons disease (PD)(NCT 01850381) for its drug candidate GM6 (also known as GM604 in the ALS trial and GM608 in the PD trial…

Personalis Introduces New Services For Cancer Research And Clinical Trials

October 20, 2014 – 5:00 am | Edit Post

Personalis, Inc., a leading genomics-based service provider, today announced it is launching an expanded portfolio of cancer research solutions based on its ACE (Accuracy and Content Enhanced) sequencing, informatics and content technology platform. Scientists from Personalis presented the new portfolio of cancer research solutions this weekend to attendees at the 2014 American Society of Human Genetics…

Epic Sciences Appoints As Chief Information Officer

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –Epic Sciences announced today the appointment of Michael Giskeas chief information officer. Mr. Giske has more than 25 years of defining, designing and implementing…

Cypher Genomics Identifies And Verifies Genetic Cause Of Rare Disease, Epileptic Encephalopathy

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –Cypher Genomics, Inc., the genome informatics company, announced today the identification of de novoKCNB1 missense mutations as a novel genetic cause of severe epileptic encephalopathy…

HealthFusion’s MediTouch?? EHR Ranked As Top 3 For Clinical Quality And Support In Medical Economics’ National Provider Survey

October 20, 2014 – 5:00 am | Edit Post

SOLANA BEACH, Calif., Oct. 20, 2014 /PRNewswire/ — HealthFusion, maker of MediTouch EHR, the leading cloud computing software for physicians, hospitals, and medical billing services, was ranked as a Top 3 Electronic Health Record (EHR…

RainDance Technologies Showcases Leading Genomic Researchers And Novel Sequencing Solutions At American Society of Human Genetics Annual Meeting

October 20, 2014 – 5:00 am | Edit Post

RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetics, today announced the speaker lineup for its upcoming customer workshop at the American Society of Human Genetics (ASHG) Annual Meeting taking place in San Diego, California Oct 18-22, 2014. RainDance will showcase its complete line of products enabling novel, non-invasive Fluid Biopsy applications for…